BacoCure Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
BacoCure General Information
Description
Developer of a novel bacterial product designed for local therapy of non-muscle invasive bladder cancer patients. The company's product is a novel mutated and inactivated uropathogenic bacteria that has anti-tumor effects via a novel and differentiated mechanism of action, enabling patients to have a better safety profile compared to Bacillus Calmette-Guerin.
Contact Information
Corporate Office
- Professor Racah Street
- Jerusalem
- Israel
Corporate Office
- Professor Racah Street
- Jerusalem
- Israel
BacoCure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Jan-2022 | Completed | Out of Business | |||
| 2. Seed Round | 01-Feb-2018 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
BacoCure FAQs
-
When was BacoCure founded?
BacoCure was founded in 2017.
-
Where is BacoCure headquartered?
BacoCure is headquartered in Jerusalem, Israel.
-
What industry is BacoCure in?
BacoCure’s primary industry is Biotechnology.
-
Is BacoCure a private or public company?
BacoCure is a Private company.
-
What is BacoCure’s current revenue?
The current revenue for BacoCure is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process